Chemotherapy, AdjuvantAdjuvants, ImmunologicRadiotherapy, AdjuvantBreast NeoplasmsCombined Modality TherapyNeoplasm Recurrence, LocalTreatment OutcomeNeoplasm StagingAdjuvants, PharmaceuticFreund's AdjuvantPrognosisDisease-Free SurvivalTamoxifenFluorouracilSurvival RateLevamisoleAntineoplastic Agents, HormonalHepatectomyAntineoplastic Combined Chemotherapy ProtocolsLymphatic MetastasisSurvival AnalysisRetrospective StudiesFollow-Up StudiesAdenocarcinomaRectal NeoplasmsPancreatectomyAromatase InhibitorsNeoadjuvant TherapyLiver NeoplasmsLymph Node ExcisionAntineoplastic AgentsPancreatic NeoplasmsColonic NeoplasmsTime FactorsColorectal NeoplasmsCyclophosphamideChemoradiotherapy, AdjuvantDigestive System Surgical ProceduresReceptors, EstrogenPneumonectomyMastectomyRandomized Controlled Trials as TopicKaplan-Meier EstimateScleral DiseasesPancreaticoduodenectomyTumor Markers, BiologicalGastrectomyNitrilesPostoperative ComplicationsNeoplasm InvasivenessLymph NodesTriazolesLung NeoplasmsTransurethral Resection of ProstateProportional Hazards ModelsLeucovorinClinical Trials as TopicAntimetabolites, AntineoplasticProspective StudiesNeurosurgical ProceduresMelanomaCarcinomaBrain NeoplasmsDoxorubicinStomach NeoplasmsNeoplasm MetastasisRecurrencePostoperative CareMultivariate AnalysisBone NeoplasmsTomography, X-Ray ComputedMethotrexateSarcomaBile Duct NeoplasmsReceptors, ProgesteronePreoperative CareImmunohistochemistryReceptor, erbB-2Predictive Value of TestsSemustineDrug Administration SchedulePostmenopausePatient SelectionCarcinoma, HepatocellularCholangiocarcinomaImmunotherapyNeoplasms, Hormone-DependentBile Ducts, IntrahepaticRisk FactorsAluminum HydroxideGastrointestinal Stromal TumorsActuarial AnalysisCisplatinColectomyAnthracyclinesMedical OncologyRisk AssessmentTegafurRetroperitoneal NeoplasmsMucoepidermoid Tumor